As of 2026-03-15, the Relative Valuation of Apyx Medical Corp (APYX) is (12.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.63 USD, the upside of Apyx Medical Corp based on Relative Valuation is -443.6%.
The range of the Relative Valuation is (12.81) - (12.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 36.1x - 41.5x | 38.2x |
| Forward P/E multiples | 30.6x - 34.9x | 32.2x |
| Fair Price | (12.81) - (12.37) | (12.47) |
| Upside | -452.8% - -440.7% | -443.6% |
| Date | P/E |
| 2026-03-13 | -10.24 |
| 2026-03-12 | -10.21 |
| 2026-03-11 | -11.08 |
| 2026-03-10 | -9.73 |
| 2026-03-09 | -9.67 |
| 2026-03-06 | -8.80 |
| 2026-03-05 | -9.19 |
| 2026-03-04 | -9.31 |
| 2026-03-03 | -8.94 |
| 2026-03-02 | -9.25 |
| 2026-02-27 | -9.22 |
| 2026-02-26 | -9.87 |
| 2026-02-25 | -9.65 |
| 2026-02-24 | -9.98 |
| 2026-02-23 | -10.07 |
| 2026-02-20 | -10.66 |
| 2026-02-19 | -10.58 |
| 2026-02-18 | -11.06 |
| 2026-02-17 | -10.83 |
| 2026-02-13 | -10.49 |
| 2026-02-12 | -10.77 |
| 2026-02-11 | -11.06 |
| 2026-02-10 | -11.23 |
| 2026-02-09 | -11.51 |
| 2026-02-06 | -10.94 |
| 2026-02-05 | -11.11 |
| 2026-02-04 | -11.20 |
| 2026-02-03 | -12.38 |
| 2026-02-02 | -12.41 |
| 2026-01-30 | -11.34 |
| 2026-01-29 | -11.42 |
| 2026-01-28 | -11.31 |
| 2026-01-27 | -11.82 |
| 2026-01-26 | -10.92 |
| 2026-01-23 | -11.20 |
| 2026-01-22 | -11.14 |
| 2026-01-21 | -11.25 |
| 2026-01-20 | -10.86 |
| 2026-01-16 | -11.25 |
| 2026-01-15 | -10.97 |
| 2026-01-14 | -10.61 |
| 2026-01-13 | -10.94 |
| 2026-01-12 | -11.31 |
| 2026-01-09 | -9.84 |
| 2026-01-08 | -9.76 |
| 2026-01-07 | -9.76 |
| 2026-01-06 | -10.04 |
| 2026-01-05 | -9.98 |
| 2026-01-02 | -9.87 |
| 2025-12-31 | -9.87 |